← Leaderboards
Jenell S Coleman
Johns Hopkins University
$4,734,272
Attributed
$7,312,660
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,312,660 · 3
By mechanism
R01$7,312,660 · 3
Top collaborators
- Okeoma O. Mmeje5 shared
- Craig Walter Hendrix4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Randall R Reed$8,439,469
- Elia J Duh$12,153,743
- Joshua T Mendell$10,907,449
- Craig Walter Hendrix$25,690,627
- Cui Yang$8,627,498
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanHigh RiskHiv InfectionsAids PreventionHiv RiskUnited StatesPublic HealthOralEmtricitabineInflammatoryHeterosexualsImmuneTenofovirSexually ActiveCellsFemaleClinical TrialsReportingPredispositionSiteSexually Transmitted DiseasesObservational StudyProgestinsContraceptive Agents
Grant awards (14)
Improving HIV Prevention Services among Socioeconomically Disadvantaged Cis-gender Women$774,104
R01 · FY2025 · MH · contact PI
Improving HIV Prevention Services among Socioeconomically Disadvantaged Cis-gender Women$786,802
R01 · FY2024 · MH · contact PI
Improving HIV Prevention Services among Socioeconomically Disadvantaged Cis-gender Women$798,380
R01 · FY2023 · MH · contact PI
Improving HIV Prevention Services among Socioeconomically Disadvantaged Cis-gender Women$216,165
R01 · FY2023 · MH · contact PI
Improving HIV Prevention Services among Socioeconomically Disadvantaged Cis-gender Women$825,894
R01 · FY2022 · MH · contact PI
âInflammation, Vaginal Microbiota, and STI/HIV Riskâ$472,668
R01 · FY2020 · HD · contact PI
âInflammation, Vaginal Microbiota, and STI/HIV Riskâ$478,965
R01 · FY2019 · HD · contact PI
Inflammation, Vaginal Microbiota, and STI/HIV Risk$229,250
R01 · FY2019 · HD · contact PI
âInflammation, Vaginal Microbiota, and STI/HIV Riskâ$484,875
R01 · FY2018 · HD · contact PI
âInflammation, Vaginal Microbiota, and STI/HIV Riskâ$490,125
R01 · FY2017 · HD · contact PI
The effect of Depo-Provera on HIV susceptibility, immune activation, and PrEP PK$438,858
R01 · FY2017 · AI
The effect of Depo-Provera on HIV susceptibility, immune activation, and PrEP PK$438,858
R01 · FY2016 · AI
The effect of Depo-Provera on HIV susceptibility, immune activation, and PrEP PK$438,858
R01 · FY2015 · AI
The effect of Depo-Provera on HIV susceptibility, immune activation, and PrEP PK$438,858
R01 · FY2014 · AI